[Drug therapy of shock]

Fortschr Med. 1978 Mar 30;96(12):653-60.
[Article in German]

Abstract

Shock is to define by clinical symptoms, measurable haemodynamic and metabolic changes, clotting failure and disorders of fluid, electrolyte and acid-base balance. It is essential to remove hypovolemia, acidosis, cardiovascular failure, pulmonary and renal insufficiency. Quite a lot of proved and controversial pharmacological substances are placed at physician's disposal. However, the mortality of cardiogenic shock and gram-negative septic shock is more than 80% respectively 30%, often caused by shock lung or irreversible injury to the kidneys. Shock due to depletion of extracellular fluid, poisoning and acute pancreatitis require specific treatment.

Publication types

  • English Abstract

MeSH terms

  • Bicarbonates / therapeutic use
  • Dehydration / drug therapy
  • Dihydroergotoxine / therapeutic use
  • Furosemide / therapeutic use
  • Glucagon / therapeutic use
  • Humans
  • Methylprednisolone / therapeutic use
  • Peritoneal Dialysis
  • Plasma Substitutes
  • Shock / drug therapy*
  • Shock, Cardiogenic / drug therapy
  • Shock, Septic / drug therapy
  • Spironolactone / therapeutic use
  • Sympathomimetics / therapeutic use
  • Theophylline / analogs & derivatives
  • Theophylline / therapeutic use

Substances

  • Bicarbonates
  • Plasma Substitutes
  • Sympathomimetics
  • Dihydroergotoxine
  • Spironolactone
  • Furosemide
  • Glucagon
  • Theophylline
  • Methylprednisolone